One year after launching its $25 million venture fund, TitletownTech has backed more than a dozen startups—the majority of which are based in Wisconsin—and has lured two companies to relocate their operations to Green Bay.
This month marks one full operational year for TitletownTech, a VC fund and venture studio led by the Packers and Microsoft that aims to make Green Bay a hub for startups and tech talent.
During the last 12 months, TitletownTech has invested in 14 startups. Two of those startups have relocated their headquarters to Green Bay following the investment: ChemDirect (California), a startup creating an online marketplace for on-demand chemical supplies, and Quantum Radius (Colorado), a startup developing faster video processing technology.
Nine of TitletownTech’s first investments are companies based in Wisconsin, TitletownTech Associate Chloe Pahl told Wisconsin Inno. The fund plans to invest in 15 companies on average each year, Pahl added. It writes checks between $100,000 and $1 million.
Currently six of its portfolio startups have moved into TitletownTech’s 13,000-square-foot office space in the Titletown complex near Lambeau Field. The Packers and Microsoft held a grand opening of the building last October, where it also revealed several of the fund’s LPs, which are made up of local Wisconsin companies like Baird, Green Bay Packaging and Sartori Cheese.
“The entrepreneurial talent drawn to the advantages that we offer with our unique network of partners and team continues to expand,” Craig Dickman, managing director at TitletownTech, said in a statement. “We’re extremely excited about the trajectory and potential of our growing portfolio.”
Other TitletownTech portfolio companies include Oculogica, an eye-tracking technology that helps diagnose concussions; Strive MedTech, a remote health care application for orthopedic surgery patients; and Trusted Health, a digital employment platform for nurses that was recently named among Forbes’ list of next billion-dollar startups. Read the full story here.